期刊文献+

重组pcDNA4 His/Max人骨形态发生蛋白9真核表达载体的构建与鉴定

Construction and identification of a recombinant pcDNA4 His/Max human bone morphogenetic protein eukaryotic expression vector
暂未订购
导出
摘要 背景:腺病毒临床应用存在安全隐患,利用真核表达载体表达蛋白为解决安全性问题提供了一种方法。目的:将人骨形态发生蛋白9的cDNA构建于pcDNA4 His/Max,得到重组真核表达载体pcDNA4 His/Max人骨形态发生蛋白9。方法:将已有的Padtrack-cmv-人骨形态发生蛋白9进行PCR扩增,电泳回收人骨形态发生蛋白9片段,将pcDNA4 His/Max用NotⅠ和KpnⅠ双酶切,得到pcDNA4His/Max酶切片段,连接人骨形态发生蛋白9和pcDNA4 His/Max片段得到重组质粒pcDNA4 His/Max人骨形态发生蛋白9,将该载体用DH5α转化,阳性克隆扩增及纯化、序列分析鉴定。结果与结论:通过PCR及序列分析证明pcDNA4 His/Max人骨形态发生蛋白9真核表达载体的人骨形态发生蛋白9基因长度为1.3kb,与报道的人骨形态发生蛋白9全长序列一致,无突变。结果证实,实验成功构建了pcDNA4 His/Max人骨形态发生蛋白9真核表达载体。 BACKGROUND: Adenovirus mediated method has been used numerously in human bone morphogenetic protein 9 (hBMP-9) induced osteogenesis researches, but the security is the most important problem. Eukaryotic expressing vector is a way to solve this question. OBJECTIVE: To reconstruct a recombinant DNA pcDNA4 His/Max hBMP-9 eukaryotic expressing vector by amplifying hBMP9 gene and then cloning into pcDNA4 His/Max. METHODS: Padtrack-cmv-hBMP-9 was amplified by PCR, and hBMP-9 gene was retrieved by electrophoresis, pcDNA4 His/Max was digested by Not I , Kpn 1 and then the hBMP-9 gene was cloned into pcDNA4 His/Max. The recombinant plasmid was transformed by DH5a, clonal expansion, and purification, and then verified by sequencing. RESULTS AND CONCLUSION: The cloned hBMP-9 gene was 1.3 kb long, having the same length and sequence of the gene that human possessed. Eukaryotic expressing vector of pcDNA4 His/Max hBMP-9 has been constructed successfully
出处 《中国组织工程研究》 CAS CSCD 2012年第24期4505-4508,共4页 Chinese Journal of Tissue Engineering Research
  • 相关文献

参考文献19

  • 1Yamamoto H,Ueno H,Ooshima A. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture[J].Journal of Biological Chemistry,1996,(27):16253-16259.
  • 2Cheng H,Jiang W,Phillips FM. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs)[J].Journal of Bone and Joint Surgery-American Volume,2003,(08):1544-1552.
  • 3Kang Q,Sun MH,Cheng H. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery[J].Gene Therapy,2004,(17):1312-1320.
  • 4Tang N,Song WX,Luo J. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling[J].Journal of Cellular and Molecular Medicine,2009,(8B):2448-2464.doi:10.1111/j.1582-4934.2008.00569.x.
  • 5Bessa PC,Cerqueira MT,Rada T. Expression,purification and osteogenic bioactivity of recombinant human BMP-4,-9,-10,-11 and -14[J].Protein Expression and Purification,2009,(02):89-94.doi:10.1016/j.pep.2008.09.014.
  • 6张道永,杨爽,吕树军,闫继东,朱天慧.重组人骨形态发生蛋白2在CHO细胞中的表达、鉴定及活性分析[J].生物工程学报,2006,22(6):968-972. 被引量:9
  • 7Xiao J,Chen LW,Chen JX. Construction of a recombinant eukaryotic expression plasmid containing human PDLIM2 gene and its biological activity[J].Plasmid,2011,(02):106-111.doi:10.1016/j.plasmid.2011.06.005.
  • 8Kiein-Nulend J,Louwerse R T,Heyligers IC. Osteogenic proteint-1(op-1,BMP7) stimulates cartilage differentiation of human and goat perichondrium tissue in vitro[J].Journal of Biomedical Materials Research,1998,(04):614-616.
  • 9Kang Q,Song WX,Luo Q. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells[J].Stem Cells and Development,2009,(04):545-559.doi:10.1089/scd.2008.0130.
  • 10Nauth A,Ristevski B,Li R. Growth factors and bone regeneration:how much bone can we expect[J].Injury.British Journal of Accident Surgery,2011,(06):574-579.

二级参考文献10

  • 1Hots G, Herr G. Bone substitute with osteoinductive biomaterialscurrent and future chinical applications. Int J Oral Maxillofac Surg,1994,23:413-420
  • 2Reddi AH. Role of morphogenetie proteins in skeletal tissue engineering and regeneration. Nat Biotechnol, 1998,16: 247-252
  • 3Nakashima M, Reddi AH. The application of bone morphogenetic proteins to dental tissue engineering. Nat Biotechnol, 2003,21(9):1025- 1032
  • 4Marshak DR, Kadonaga JK, Burgess RR et al. Strategies for Protein Purification and Characterization: A Laboratory Course Manual. New York:Cold Spring Harbor Laboratory Press, 1996
  • 5E Z(鄂征).Technology of Tissue Culture and Molecular Cytology.2^nd ed, Beijing: Beijing Press, 1997
  • 6Katagiri T, Yamaguehi A, Komaki M et al. Bone morphogenetic protein-2 eonverts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol, 1994,127:1755 - 1766
  • 7Sandhu HS. Bone morphogenetie proteins and spinal surgery.Spine, 2003,28: S64-S73
  • 8Zou Z, Sun PD. Overexpression of human transforming growth factor-betal using a recombinant CHO cell expression system.Protein Expr Purif, 2004,37(2):265 - 272
  • 9Janckila AJ, Parthasarathy RN, Parthasarathy LK et al. Stable expression of human tartrate-resistant acid phosphatase isoforms by CHO cells. Clin Chim Acta, 2002,326(1-2):113-122
  • 10Hwang Su-Jeong, Choi Han-Ho, Kim Kyung-Tae et al. Expression and purification of recombinant human angiopoietin-2 produced in Chinese hamster ovary cells. Protein Expr Purif, 2005,39(2): 175-183

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部